Anzeige
Anzeige

Current Issue

2017: Issue 7 2017 (pp. 1217-1454)

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

25 articles
1.

C. Weber (1, 2), G. Y. H. Lip

(1) Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany; (2) DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany

Thromb Haemost 2017 117: 1217-1218

https://doi.org/10.1160/TH17-05-0350

[Summary] [Free PDF] [Export citation]
2.

S. Schulman (1, 2), W. Ageno (3), S. V. Konstantinides (4, 5)

(1) Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada; (2) Karolinska Institutet, Stockholm, Sweden; (3) Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy; (4) Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; (5) Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece

Thromb Haemost 2017 117 7: 1219-1229

https://doi.org/10.1160/TH16-10-0823

[Summary] [Free PDF] [Export citation]
3.
Stroke prevention in atrial fibrillation: Past, present and future
Comparing the guidelines and practical decision-making

G. Y. H. Lip, B. Freedman (1, 2), R. De Caterina (3), T. S. Potpara (4, 5)

(1) Heart Research Institute, Charles Perkins Centre, Sydney Medical School, University of Sydney, Sydney, Australia; (2) Department of Cardiology and Anzac Research Institute, Concord Hospital, University of Sydney, Australia; (3) G. d’Annunzio” University and Center of Excellence on Aging – CeSI-Met, Chieti, Italy; (4) School of Medicine, Belgrade University, Belgrade, Serbia; (5) Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia

Thromb Haemost 2017 117 7: 1230-1239

https://doi.org/10.1160/TH16-11-0876

[Summary] [Free PDF] [Export citation]
4.

D. Sibbing (1, 2), D. J. Angiolillo (3), K. Huber

(1) Department of Cardiology, Ludwig-Maximilians-Universität München (LMU Munich), Munich, Germany; (2) DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany; (3) Division of Cardiology at the University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA

Thromb Haemost 2017 117 7: 1240-1248

https://doi.org/10.1160/TH16-12-0963

[Summary] [Free PDF] [Export citation]
5.

J. Jamasbi (1), K. Ayabe (2), S. Goto (2), B. Nieswandt (3), K. Peter (4), W. Siess (1, 5)

(1) Institute for the Prevention of Cardiovascular Diseases, LMU Munich, Munich, Germany; (2) Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan; (3) Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany; (4) Atherothrombosis and Vascular Biology, Baker IDI Heart and Diabetes Institute, Melbourne, Australia; (5) DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany

Thromb Haemost 2017 117 7: 1249-1257

https://doi.org/10.1160/TH16-12-0911

[Summary] [Free PDF] [Export citation]
6.

C. Weber (1, 2, 3), L. Badimon (4), F. Mach (5), E. P. C. van der Vorst (1)

(1) Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany; (2) DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany; (3) Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands; (4) Cardiovascular Research Center, Catalan Institute of Cardiovascular Science, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; (5) Cardiology Division, Geneva University Hospital, Geneva, Switzerland

Thromb Haemost 2017 117 7: 1258-1264

https://doi.org/10.1160/TH16-10-0814

[Summary] [Free PDF] [Export citation]
7.

H. ten Cate (1, 2), T. M. Hackeng (3), P. García de Frutos (4)

(1) Department of Internal Medicine, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands; (2) Thrombosis Expert Center, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands; (3) Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands; (4) Department of Cell Death and Proliferation, IIBB-CSIC and IDIBAPS, Barcelona, Spain

Thromb Haemost 2017 117 7: 1265-1271

https://doi.org/10.1160/TH17-02-0079

[Summary] [Free PDF] [Export citation]
8.

K. T. Preissner (1), H. Herwald (2)

(1) Department of Biochemistry, Medical School, Justus-Liebig-University, Giessen, Germany; (2) Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden

Thromb Haemost 2017 117 7: 1272-1282

https://doi.org/10.1160/TH-16-11-0858

[Summary] [Free PDF] [Export citation]
9.

J. I. Weitz (1), J. Harenberg (2)

(1) Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada; (2) Medical Faculty Mannheim, Ruprecht-Karls University Heidelberg, Mannheim, Germany

Thromb Haemost 2017 117 7: 1283-1288

https://doi.org/10.1160/TH16-10-0807

[Summary] [Free PDF] [Export citation]
10.

G. Breier (1), T. Chavakis (2), E. Hirsch (3)

(1) Division of Medical Biology, Department of Psychiatry, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Germany; (2) Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Germany; (3) Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy

Thromb Haemost 2017 117 7: 1289-1295

https://doi.org/10.1160/TH17-05-0325

[Summary] [Free PDF] [Export citation]
11.
Microvesicles in vascular homeostasis and diseases
Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology

V. C. Ridger (1), C. M. Boulanger (2, 3), A. Angelillo-Scherrer (4, 5), L. Badimon (6, 7), O. Blanc-Brude (2, 3), M.-L. Bochaton-Piallat (8), E. Boilard (9), E. I. Buzas (10), A. Caporali (11), F. Dignat-George (12, 13), P. C. Evans (1), R. Lacroix (12, 13), E. Lutgens (14, 15), D. F. J. Ketelhuth (16), R. Nieuwland (17), F. Toti (18), J. Tunon (19, 20), C. Weber (15, 21), I. E. Hoefer (22)

(1) Department of Infection, Immunity and Cardiovascular Disease, Faculty of Medicine, Dentistry and Health and the INSIGNEO Institute for In Silico Medicine, University of Sheffield, Sheffield, UK; (2) INSERM UMR-S 970, Paris Cardiovascular Research Center – PARCC, Paris, France; (3) Université Paris Descartes, Sorbonne Paris Cité, Paris, France; (4) Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; (5) Department of Clinical Research, University of Bern, Bern, Switzerland; (6) Cardiovascular Research Center (CSIC-ICCC), IIB-Sant Pau, Barcelona, Spain; (7) Cardiovascular Research Chair, UAB, Barcelona, Spain; (8) Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; (9) Centre de Recherche du CHU de Québec, Université Laval, Department of Infectious diseases and Immunity, Quebec City, Quebec, Canada; (10) Semmelweis University, Department of Genetics, Cell- and Immunobiology, Budapest, Hungary; (11) University/British Heart Foundation Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK; (12) Aix-Marseille University, INSERM, VRCM, UMR-S1076, UFR de Pharmacie, Marseille, France; (13) Department of Hematology and Vascular Biology, CHU La Conception, APHM, Marseille, France; (14) Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, The Netherlands; (15) Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany; (16) Cardiovascular Medicine Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden; (17) Laboratory of Experimental Clinical Chemistry, Vesicle Observation Center, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; (18) Faculty of Pharmacy, UMR CNRS 7213, University of Strasbourg, Strasbourg, France; (19) IIS-Fundación Jiménez Díaz, Madrid, Spain; (20) Autónoma University, Madrid, Spain; (21) Cardiovascular Research Institute Maastricht (CARIM), 6229 ER Maastricht, The Netherlands; (22) Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK

Thromb Haemost 2017 117 7: 1296-1316

https://doi.org/10.1160/TH16-12-0943

[Summary] [Free PDF] [Export citation]
12.

S. Schulman (1), D. Singer (2), W. Ageno (3), I. B. Casella (4), M. Desch (5), S. Z. Goldhaber (6)

(1) Thrombosis and Atherosclerosis Research Institute and McMaster University, Hamilton, Ontario, Canada; (2) Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA; (3) University of Insubria, Varese, Italy; (4) University of Sao Paulo, Sao Paulo, Brazil; (5) Boehringer Ingelheim, Germany; (6) Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA

Thromb Haemost 2017 117 7: 1317-1325

https://doi.org/10.1160/TH17-01-0065

[Summary] [Free PDF] [Export citation]
13.
Open Access
The management of acute venous thromboembolism in clinical practice
Results from the European PREFER in VTE Registry

A. T. Cohen (1), A. K. Gitt (2), R. Bauersachs (3), E.-M. Fronk (4), P. Laeis (4), P. Mismetti (5), M. Monreal (6), S. N. Willich (7), P. Bramlage (8), G. Agnelli (9), on behalf of the PREFER in VTE Scientific Steering Committee and the PREFER in VTE Investigators

(1) Guys and St Thomas’ Hospitals NHS Foundation Trust, King’s College, London, UK; (2) Herzzentrum Ludwigshafen Med. Klinik B, Ludwigshafen, Germany; (3) Center of Thrombosis and Haemostasis, University of Mainz, Mainz, Germany; (4) Daiichi Sankyo Europe GmbH, Munich, Germany; (5) CHU Saint-Etienne Hopital Nord, Saint Etienne Cedex 2, France; (6) Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; (7) Charité – Universitätsmedizin Berlin, Germany; (8) Institute for Pharmacology and Preventive Medicine, Mahlow, Germany; (9) University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy

Thromb Haemost 2017 117 7: 1326-1337

https://doi.org/10.1160/TH16-10-0793

[Summary] [Free PDF] [Export citation]
14.

S. Peng (1, 2), G. Xue (1, 3), L. Gong (1), C. Fang (4, 5), J. Chen (6), C. Yuan (7), Z. Chen (1), L. Yao (6), B. Furie (4), M. Huang (1, 7)

(1) State Key Laboratory of Structural Chemistry and Danish-Chinese Centre for Proteases and Cancer, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, China; (2) College of life sciences, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China; (3) College of Life science, Fujian Normal University, Fuzhou, Fujian, China; (4) Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA; (5) School of Basic Medicine, Tongji Medical College, Huazhong University of Science & Technology, Huazhong, China; (6) Qingdao Institute of Biomass Energy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China; (7) Fuzhou University,Fuzhou, Fujian, China

Thromb Haemost 2017 117 7: 1338-1347

https://doi.org/10.1160/TH16-11-0891

[Summary] [PDF] [Pay per view] [Export citation]
15.
Open Access

Online Supplementary Material

T. Kitazawa (1), K. Esaki (2), T. Tachibana (1), S. Ishii (2), T. Soeda (2), A. Muto (2), Y. Kawabe (2), T. Igawa (2), H. Tsunoda (1), K. Nogami (3), M. Shima (3), K. Hattori (1)

(1) Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan; (2) Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan; (3) Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan

Thromb Haemost 2017 117 7: 1348-1357

https://doi.org/10.1160/TH17-01-0030

[Summary] [Free PDF] [Export citation]
16.

Online Supplementary Material

C. Chen (1), L. Yang (2), B. O. Villoutreix (3), X. Wang (4), Q. Ding (4), A. R. Rezaie (2)

(1) State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; (2) Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA; (3) Inserm U973, Université Paris Diderot, Sorbonne Paris Cité, Molécules Thérapeutiques In Silico, Paris, France; (4) Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Thromb Haemost 2017 117 7: 1358-1369

https://doi.org/10.1160/TH17-01-0043

[Summary] [PDF] [Pay per view] [Export citation]
17.

Online Supplementary Material

M. Honickel (1), H. M. Spronk (2), R. Rossaint (1), C. Stoppe (1), J. van Ryn (3), H. ten Cate (2), O. Grottke (1)

(1) Department of Anesthesiology, RWTH Aachen University Hospital, Aachen, Germany; (2) Clinical Thrombosis and Hemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands; (3) Metabolic Diseases Research, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany

Thromb Haemost 2017 117 7: 1370-1378

https://doi.org/10.1160/TH16-11-0824

[Summary] [PDF] [Pay per view] [Export citation]
18.

Online Supplementary Material

S. Stojkovic (1), Å. Thulin (2), L. Hell (3), B. Thaler (1), S. Rauscher (4), J. Baumgartner (1), M. Gröger (4), C. Ay (3), S. Demyanets (5), C. Neumayer (6), I. Huk (6), A. Spittler (4, 6), K. Huber (7), J. Wojta (1, 4, 7, 8), A. Siegbahn (2), M. Åberg (2)

(1) Department of Internal Medicine II, Medical University of Vienna, Austria; (2) Department of Medical Sciences, Clinical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden; (3) Department of Internal Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria; (4) Core Facilities, Medical University of Vienna, Austria; (5) Department of Laboratory Medicine, Medical University of Vienna, Austria; (6) Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Austria; (7) Sigmund FReud Private University, Medical School, Vienna, Austria; (8) Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna Austria

Thromb Haemost 2017 117 7: 1379-1390

https://doi.org/10.1160/TH16-10-0784

[Summary] [PDF] [Pay per view] [Export citation]
19.

M. Tatour (1), M. Shapira (2), E. Axelman (1), S. Ghanem (1), A. Keren-Politansky (3), L. bonstein (4), B. Brenner (1), Y. Nadir (1)

(1) Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa, Israel; (2) Hematology Laboratory, Hillel Yaffe Medical Center, Hadera, Israel; (3) Hematology Laboratory, Rambam Health Care Campus, Haifa, Israel; (4) Blood bank and platelet & neutrophil immunology laboratories, Rambam Health Care Campus, Haifa, Israel

Thromb Haemost 2017 117 7: 1391-1401

https://doi.org/10.1160/TH16-10-0766

[Summary] [PDF] [Pay per view] [Export citation]
20.

Online Supplementary Material

L. B. M. Dosier (1), V. J. Premkumar (2), H. Zhu (2), I. Akosman (2), M. F. Wempe (3), T. J. McMahon (2, 4)

(1) Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA; (2) Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA; (3) Department of Pharmaceutical Sciences, University of Colorado, Denver, Colorado, USA; (4) Departments of Research and Development and Medicine, Veterans Affairs Medical Center, Durham, North Carolina, USA

Thromb Haemost 2017 117 7: 1402-1411

https://doi.org/10.1160/TH16-05-0373

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-25